|
Healthcare professional reported injecting a patient in the lips with one syringe of juvéderm vollure¿ xc.A month later, the patient reported ¿blisters¿ on the lips, a ¿veiny¿ upper lip, and ¿nodules¿ and was treated that day with valtrex 500 mg 1 per day for 10 days.Nine days later, the patient was treated with clindamycin 200 mg 3 times per day for 10 days and a medrol dosepak.Six days later, the patient was given another medrol dosepak.Eight days later, a physical exam was performed, and the patient was advised to return in 4 weeks.Six weeks later, another physical exam was performed, with 90% of the event resolved.A month later, another physical exam was performed that showed ¿blisters (not open) and nodules.¿ the patient reported the lips looked fine for 8 days.Event was ongoing.
|
|
Clarification to e.1.Address 1: (b)(6).Clarification to h.6.Type of investigation code: the filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.The event is a physiological complication and analysis of the device generally does not assist abbvie in determining a probable cause for this event.Further information regarding event, product, or patient details has been requested.No additional information is available at this time.A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.This is a known potential adverse event addressed in the product labeling.
|